AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Coffe, C Benguella, M Domy, M Cottier, D Guignier, F N'gondara, JP Carrere, A Masse, M Naegelen, C Biggio, B Tiberghien, P Herve, P Bouzgarrou, R Maurel, JP Vezon, G Vidal, M Quainon, F Benamara, A Lamy, B Beaumont, JL Bierling, P Gondrexon, G Schooneman, F Janot, C Villard, F Huart, JJ
Citation: C. Coffe et al., Plateletpheresis concentrates produced with the COMTEC cell separator: theFrench experience, TRANSF AP S, 25(1), 2001, pp. 67-72

Authors: Achour, SL Dojat, M Rieux, C Bierling, P Lepage, E
Citation: Sl. Achour et al., Application of information technology - A UMLS-based knowledge acquisitiontool for rule-based clinical decision support system development, J AM MED IN, 8(4), 2001, pp. 351-360

Authors: El Kassar, N Legouvello, S Joseph, CM Salesses, P Rieux, C Cordonnier, C Vernant, JP Farcet, JP Bierling, P Kuentz, M
Citation: N. El Kassar et al., High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs, BONE MAR TR, 27(1), 2001, pp. 35-43

Authors: Hiesse, C Busson, M Buisson, C Farahmand, H Bierling, P Benbunan, M Bedrossian, J Aubert, P Glotz, D Loirat, C Rondeau, E Viron, B Bleux, H Lang, P
Citation: C. Hiesse et al., Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation, KIDNEY INT, 60(1), 2001, pp. 341-349

Authors: Lang, P Buisson, C Fruchaud, G Desvaux, D Hemery, F Seror, T Baron, C Dahmane, D Pastural, M Beaujan, F Chopin, D Abbou, C Remy, P Grimbert, P Weil, B Bierling, P
Citation: P. Lang et al., Long-term results of posttransplantation blood transfusion on kidney allograft survival, TRANSPLAN P, 33(1-2), 2001, pp. 1202-1203

Authors: Lee, K Gane, P Roudot-Thoraval, F Godeau, B Bachir, D Bernaudin, F Cartron, JP Galacteros, F Bierling, P
Citation: K. Lee et al., The nonexpression of CD36 on reticulocytes and mature red blood cells doesnot modify the clinical course of patients with sickle cell anemia, BLOOD, 98(4), 2001, pp. 966-971

Authors: Vantelon, JM Godeau, B Andre, C Bierling, P
Citation: Jm. Vantelon et al., Screening for autoimmune markers is unnecessary during follow-up of adultswith autoimmune thrombocytopenic purpura and no autoimmune markers at onset, THROMB HAEM, 83(1), 2000, pp. 42-45

Authors: Le Louet, H Ruivart, M Bierling, P Duche, JC Godeau, B
Citation: H. Le Louet et al., Lack of relevance of the acetylator status on dapsone response in chronic autoimmune thrombocytopenic purpura, AM J HEMAT, 62(4), 1999, pp. 251-252

Authors: Godeau, B Bierling, P
Citation: B. Godeau et P. Bierling, Intravenous immunoglobulins and autoimmune thrombocytopenic purpura., REV MED IN, 20, 1999, pp. 440S-443S

Authors: Godeau, B Bierling, P
Citation: B. Godeau et P. Bierling, The treatment of patients with autoimmune thrombocytopenia with intravenous IgG-anti-D, VOX SANGUIN, 76(4), 1999, pp. 252-253

Authors: Lee, K Godeau, B Fromont, P Plonquet, A Debili, N Bachir, D Reviron, D Gourin, J Fernandez, E Galacteros, F Bierling, P
Citation: K. Lee et al., CD36 deficiency is frequent and can cause platelet immunization in Africans, TRANSFUSION, 39(8), 1999, pp. 873-879

Authors: Godeau, B Caulier, MT Decuypere, L Rose, C Schaeffer, A Bierling, P
Citation: B. Godeau et al., Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0 center dot 5 and 1 g/kg bw, BR J HAEM, 107(4), 1999, pp. 716-719

Authors: Ruivard, M Caulier, MT Vantelon, JM Tournilhac, O Schaeffer, A Godeau, B Bierling, P
Citation: M. Ruivard et al., The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura, BR J HAEM, 105(4), 1999, pp. 1130-1132

Authors: Rieux, C Lee, K Lavaud, A Bierling, P
Citation: C. Rieux et al., Transfusion of platelet concentrates., ANN MED IN, 150(8), 1999, pp. 631-641

Authors: Tamouza, R Visser, CJT El Kassar, N Poirier, JC Toubert, A Bierling, P Raffoux, C Charron, D
Citation: R. Tamouza et al., Identification of a novel HLA-B51 variant: HLA-B*5112, TISSUE ANTI, 52(5), 1998, pp. 489-491
Risultati: 1-15 |